Author:
Michalova Kira,Lim Lyndell
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference60 articles.
1. International Study Group for Behcet’s Disease: Criteria for diagnosis of Behçet’s disease. Lancet 1990, 335:1078–1080.
2. Sfikakis PP, Theodossiadis PG, Katsiari CG, et al.: Effect of infliximab on sight-threatening panuveitis in Behçet’s disease. Lancet 2001, 358:295–296.
3. Ohno S, Nakamura S, Hori S, et al.: Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis. J Rheumatol 2004, 31:1362–1368.
4. Sfikakis PP, Kaklamanis PH, Elezoglou A, et al.: Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med 2004, 140:404–406.
5. Tugal-Tutkun I, Mudun A, Urgancioglu M, et al.: Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease. Arthritis Rheum 2005, 52:2478–2484.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献